Rackwitz L, Djouad F, Janjanin S, Nöth U, Tuan R S
Cartilage Biology and Orthopaedics Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA.
Orthopaedic Center for Musculoskeletal Research, König-Ludwig-Haus, Julius-Maximilians University, Würzburg, Germany.
Osteoarthritis Cartilage. 2014 Aug;22(8):1148-57. doi: 10.1016/j.joca.2014.05.019. Epub 2014 Jun 2.
The long-term performance of cell-seeded matrix-based cartilage constructs depends on (1) the development of sufficient biomechanical properties, and (2) lateral integration with host tissues, both of which require cartilage-specific matrix deposition within the scaffold. In this study, we have examined the potential of tissue-engineered cartilage analogs developed using different cell types, i.e., mesenchymal stem cells (MSCs) vs chondrocytes and de-differentiated chondrocytes, in an established "construct in cartilage ring" model.
Cell-laden constructs of differentiated chondrocytes, de-differentiated chondrocytes after two, five or eight population doublings, and MSCs were either implanted into a native cartilage ring immediately after fabrication (immature group) or pre-treated for 21 days in a transforming growth factor-β3 (TGF-β3) containing medium prior to implantation. After additional culture for 28 days in a serum-free, chemically defined medium, the extent of lateral integration, and biochemical and biomechanical characteristics of the implants as hybrid constructs were assessed.
The quality of integration, the amount of accumulated cartilage-specific matrix components and associated biomechanical properties were found to be highest when using differentiated chondrocytes. De-differentiation of chondrocytes negatively impacted the properties of the implants, as even two population doublings of the chondrocytes in culture significantly lowered cartilage repair capacity. In contrast, MSCs showed chondrogenic differentiation with TGF-β3 pre-treatment and superior integrational behavior.
Chondrocyte expansion and de-differentiation impaired the cell response, resulting in inferior cartilage repair in vitro. With TGF-β3 pre-treatment, MSCs were able to undergo sustained chondrogenic differentiation and exhibited superior matrix deposition and integration compared to de-differentiated chondrocytes.
基于细胞接种基质的软骨构建物的长期性能取决于:(1)发展出足够的生物力学特性,以及(2)与宿主组织的横向整合,这两者都需要在支架内沉积软骨特异性基质。在本研究中,我们在已建立的“软骨环内构建物”模型中,研究了使用不同细胞类型(即间充质干细胞(MSC)与软骨细胞和去分化软骨细胞)开发的组织工程软骨类似物的潜力。
将分化的软骨细胞、经过2、5或8次群体倍增后的去分化软骨细胞以及MSC的载细胞构建物,在制造后立即植入天然软骨环(未成熟组),或在植入前于含有转化生长因子-β3(TGF-β3)的培养基中预处理21天。在无血清、化学成分确定的培养基中再培养28天后,评估植入物作为混合构建物的横向整合程度、生化和生物力学特性。
发现使用分化的软骨细胞时,整合质量、积累的软骨特异性基质成分的量以及相关的生物力学特性最高。软骨细胞的去分化对植入物的特性产生负面影响,因为即使培养中的软骨细胞进行两次群体倍增也会显著降低软骨修复能力。相比之下,MSC在TGF-β3预处理后表现出软骨生成分化和更好的整合行为。
软骨细胞的扩增和去分化损害了细胞反应,导致体外软骨修复效果较差。通过TGF-β3预处理,MSC能够进行持续的软骨生成分化,并且与去分化软骨细胞相比,表现出更好的基质沉积和整合。